Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gammex is a leading provider of quality assurance (QA) tools and laser alignment systems for the diagnostic imaging and radiation oncology markets. Founded in 1969, the company specializes in developing phantoms and lasers that ensure the accuracy and safety of medical imaging and treatment equipment. Its product portfolio includes CT, ultrasound, and MRI phantoms, as well as patient positioning lasers used in linear accelerators. Gammex was acquired by Sun Nuclear in 2014 and is now part of Mirion Technologies' Medical group. The company's solutions are essential for clinical compliance and the delivery of precise radiation doses. Its innovations in tissue-equivalent materials have set industry standards for medical physics testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gammex.